Mitochondria-targeted cyclometalated iridium-β-carboline complexes as potent non-small cell lung cancer therapeutic agents
Metallomics · 2023
DOI: 10.1093/mtomcs/mfad035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metallomics, 2023. Verfasst von Jincan Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Computer-Aided Drug Design of Dongguan City, Key Laboratory for Research and Development of Natural Drugs of Guangdong Province, Sc…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Antineoplastic Agents, Coordination Complexes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Natural products and metals play a crucial role in cancer research and the development of antitumor drugs. We designed and synthesized three new carboline-based cyclometalated iridium complexes [Ir(C-N)2(PPβC)](PF6), where PPβC = N-(1,10-phenanthrolin-5-yl)-1-phenyl-9H-pyrido[3,4-b]indole-3-carboxamide, C-N = 2-phenylpyridine (ppy, Ir1), 2-(2,4-difluorophenyl) pyridine (dfppy, Ir2), 7,8-benzoquinoline (bzq, Ir3), by combining iridium with β-carboline derivative. These iridium complexes exhibited high potential antitumor effects after being promptly taken up by A549 cells. Accumulating in mitochondria rapidly and preferentially, Ir1-3 caused a series of changes in mitochondrial events, including the loss of mitochondrial membrane potential, the depletion of cellular ATP, and the elevation of reactive oxygen species, leading to significant death of A549 cells. Moreover, the activation of intracellular caspase pathway and apoptosis was further validated to contribute to iridium complexes-induced cytotoxicity. These novel iridium complexes exerted a prominent inhibitory effect on tumor growth in a three-dimensional multicellular tumor spheroid model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Computer-Aided Drug Design of Dongguan City, Key Laboratory for Research and Development of Natural Drugs of Guangdong Province, School of Pharmacy, Guangdong Medical University, Dongguan, Guangdong 52…
- The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, Guangdong 524023, P.R. China.
- The Marine Biomedical Research Institute of Guangdong Zhanjiang, Zhanjiang, Guangdong 524023, P.R. China.
- Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, WesternAustralia6150, Australia.
- College of Nursing and Health, Zhengzhou University, Zhengzhou 450001, P.R. China.
ORCID-Profile: Lanmei Chen
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chen, J., Guo, X., Li, D., Tang, H., Gao, J., Yu, W., Zhu, X., Sun, Z., Huang, Z., & Chen, L. (2023). Mitochondria-targeted cyclometalated iridium-β-carboline complexes as potent non-small cell lung cancer therapeutic agents. Metallomics. https://doi.org/10.1093/mtomcs/mfad035
Vancouver
Chen J, Guo X, Li D, Tang H, Gao J, Yu W, et al. Mitochondria-targeted cyclometalated iridium-β-carboline complexes as potent non-small cell lung cancer therapeutic agents. Metallomics. 2023. doi:10.1093/mtomcs/mfad035
BibTeX
@article{Chen2023,
author = {Chen, Jincan and Guo, Xinhua and Li, Dunhui and Tang, Hong and Gao, Jie and Yu, Wenzhu and Zhu, Xufeng and Sun, Zirong and Huang, Zunnan and Chen, Lanmei},
title = {Mitochondria-targeted cyclometalated iridium-β-carboline complexes as potent non-small cell lung cancer therapeutic agents},
journal = {Metallomics},
year = {2023},
doi = {10.1093/mtomcs/mfad035}
}
EUVIMED